Gsk (GSK) Change in Inventory (2009 - 2017)

Gsk (GSK) posted quarterly Change in Inventory of -$612.1 million for Q4 2017, down 263.36% quarter-over-quarter from -$168.4 million in Q4 2015.

Gsk (GSK) Change in Inventory (2009 - 2017) Analysis & Trends

Gsk's Change in Inventory history runs 8 years deep, the most recent figure standing at -$612.1 million for Q4 2017.

In Q4 2017, Change in Inventory changed N/A year-over-year to -$612.1 million; the TTM figure through Dec 2017 stood at -$1.5 billion (changed N/A YoY), while the FY2018 annual figure was $68.1 million, up 111.47% from the prior year.
Change in Inventory for Q4 2017 stood at -$612.1 million, down from -$168.4 million in the prior quarter.
The five-year high for Change in Inventory was $153.8 million in Q4 2013, with the low at -$838.1 million in Q4 2014.
The 4-year median for Change in Inventory is -$390.2 million (2017), against an average of -$366.2 million.
The sharpest annual moves came in 2013 and 2014: Change in Inventory jumped 158.87% in 2013, then plunged 644.92% in 2014.
Gsk's Change in Inventory stood at $153.8 million in 2013, then slumped by 644.92% to -$838.1 million in 2014, then jumped by 79.9% to -$168.4 million in 2015, then slumped by 263.36% to -$612.1 million in 2017.
Business Quant data shows GSK's Change in Inventory at -$612.1 million in Q4 2017, -$168.4 million in Q4 2015, and -$838.1 million in Q4 2014.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change in Inventory (Qtr)
1	Johnson & Johnson	652.20 Bn	631.44 Bn	17.26 Bn	571.00 Mn
2	AbbVie	469.51 Bn	462.94 Bn	12.70 Bn	143.00 Mn
3	Merck	376.81 Bn	369.67 Bn	12.21 Bn	-
4	Novartis Ag	303.04 Bn	295.35 Bn	11.24 Bn	-
5	Astrazeneca	257.61 Bn	252.71 Bn	12.86 Bn	-
6	Amgen	237.37 Bn	223.38 Bn	7.24 Bn	31.00 Mn
7	Gilead Sciences	181.73 Bn	178.55 Bn	6.22 Bn	145.00 Mn
8	Pfizer	159.66 Bn	147.96 Bn	10.94 Bn	-
9	Gsk	106.24 Bn	102.07 Bn	8.24 Bn	-
10	Sanofi	55.07 Bn	47.69 Bn	10.79 Bn	-

Download Data